Treatment Disparities in Parkinson's Disease
Treatment Disparities in Parkinson's Disease
复制标题
DOI：
10.1002/ana.21774
复制
发表时间：
2009-08-01
影响因子：
11.2
通讯作者：
Mandell, David S.
中科院分区：
文献类型：
--
作者：
Dahodwala, Nabila;Xie, Ming;Mandell, David S.
我们试图找出帕金森病 (PD) 治疗中的种族差异。我们使用宾夕法尼亚州医疗补助索赔确定了 307 例帕金森病事件病例，并提取了诊断后 6 个月内的药物、物理治疗和医疗就诊索赔。在控制年龄、性别和地理位置后，非裔美国人接受任何 PD 治疗的可能性比白人低四倍（比值比，0.24；95% 置信区间，0.09-0.64），特别是指定药物。在具有相同医疗保险的群体中，PD治疗存在差异。医生和社区对帕金森病治疗中的种族差异的认识是解决医疗保健差异的第一步。
We sought to identify racial disparities in the treatment of Parkinson's disease (PD). We identified 307 incident PD cases using Pennsylvania State Medicaid claims, and extracted claims for medications, physical therapy, and healthcare visits for the 6 months after diagnosis. After controlling for age, sex, and geography, African-Americans were four times less likely than whites to receive any PD treatment (odds ratio, 0.24; 95% confidence interval, 0.09-0.64), especially indicated medications. In a group with the same healthcare insurance, disparities in PD treatment exist. Physician and community awareness of these racial differences in PD treatment is the first step in addressing healthcare disparities.